By Dr. Chinta Sidharthan New research highlights how elevated levels of the iron-regulating hormone hepcidin contribute to ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

The researchers note that roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor, which targets inflammatory pathways central ...

Sufficient data from a 12-week non-clinical toxicology study of VYN202 in dogs would be required in order to resume the trial in male clinical subjects, and the design of this toxicology study has ...

While the pathogenesis of psoriasis is complex and involves multiple steps, researchers highlight three key steps in the pathogenesis of psoriasis: T-cell activation by antigen in the lymph nodes ...

Psoriasis is a chronic, inflammatory, hyperproliferative skin disease with an etiology and pathogenesis that have undergone intense investigation during the past decade.

Mice showing the first symptoms of a psoriasis-like phenotype were injected with anti-VEGF antibodies (n = 12) or an IgG isotype control (n = 8) every 48 hours for 8 days. By days 23–24, skin ...

AbbVie has announced that it will be expanding its immunology capabilities by acquiring Capstan Therapeutics for up to $2.1bn ...

The pathogenesis of psoriasis involves the IL-17/IL-23 axis, which plays a crucial role in disease development. PD-1 inhibitor-induced psoriasis is believed to result from prolonged neutrophil ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...